Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$16.75
-1.91-10.24%
At close: Dec 17, 4:00 PM EST
$16.76
0.010.06%
After Hours: 6:45 PM EST
Comments
Loading...
Monte Rosa Therapeutics (GLUE) Stock Price, Quote, News & History
GLUENASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Monte Rosa Therapeutics (GLUE) stock?
You can purchase shares of Monte Rosa Therapeutics (NASDAQ:GLUE) through any online brokerage.
Who are Monte Rosa Therapeutics (GLUE) competitors?
Other companies in Monte Rosa Therapeutics’s space includes: Precigen Inc (NASDAQ:PGEN), MoonLake Immunotherapeutics (NASDAQ:MLTX), Immatics NV (NASDAQ:IMTX), CureVac NV (NASDAQ:CVAC) and NuCana PLC (NASDAQ:NCNA).
What is the forecast, or price target, for Monte Rosa Therapeutics (GLUE) stock?
Monte Rosa Therapeutics has a consensus price target of $16.00.
What is the current price for Monte Rosa Therapeutics (GLUE)?
The stock price for Monte Rosa Therapeutics (NASDAQ: GLUE) is $16.76 last updated December 17, 2025 at 6:45 PM EST.
Does Monte Rosa Therapeutics (GLUE) pay a dividend?
There are no upcoming dividends for Monte Rosa Therapeutics.
When is Monte Rosa Therapeutics (NASDAQ:GLUE) reporting earnings?
Monte Rosa Therapeutics does not have any upcoming earnings scheduled.
Is Monte Rosa Therapeutics (GLUE) going to split?
There is no upcoming split for Monte Rosa Therapeutics.
What sector and industry does Monte Rosa Therapeutics (GLUE) operate in?
Monte Rosa Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
